Log In
Print this Print this

metatinib tromethamine

  Manage Alerts
Collapse Summary General Information
Company Simcere Pharmaceutical Group
DescriptionOral BCR-ABL tyrosine kinase inhibitor
Molecular Target BCR-ABL tyrosine kinase (BCR-ABL)
Mechanism of ActionBCR-ABL tyrosine kinase inhibitor
Therapeutic ModalitySmall molecule
Latest Stage of DevelopmentPhase I
Standard IndicationSolid tumors
Indication DetailsTreat solid tumors
Regulatory Designation

 Product Details
 Archive Items are loading loading
Collapse Summary Deals Information
 Deals Details
Get a free BioCentury trial today